Global mental health care company, COMPASS Pathways has joined the Psychiatry Consortium, bringing additional expertise and insights to the group.
The Alderley Park Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s national COVID testing, last week processed its 4 millionth test since its launch at the start of the pandemic.
The national programme, to develop and progress start-up oncology projects, is being launched by Bruntwood SciTech at Alderley Park – the UK’s largest single site life science campus – with funding from Innovate UK and Cancer Research UK.
National UK SPINE initiative created to help us stay healthy in later years.
The Alderley Park Lighthouse Lab in Cheshire plays a key role in supporting the government’s drive to increase UK testing capacity.
Validated research tool to be used to predict disease severity and individual therapeutic response to COVID-19 in aid of rapid vaccine and drug development.
Sixfold Bioscience and Medicines Discovery Catapult (MDC) awarded Innovate UK grant to pursue ground-breaking project.
Today, Medicines Discovery Catapult (MDC) announce the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators.
Medicines Discovery Catapult announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m Strength in Places Fund, along with project partner Cheshire & Warrington Local Enterprise Partnership (LEP).
Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of the Getting Building Fund for investment in schemes in Cheshire and Warrington.
See how we can help support you with your next drug discovery project.
Speak to us